SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-19-002055
Filing Date
2019-08-06
Accepted
2019-08-06 07:11:23
Documents
34
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 6-K zk1923342.htm 6-K 9265
2 REGISTRANT'S PRESS RELEASE DATED AUGUST 6, 2019 exhibit_1.htm EX-99 319204
3 CONSOLIDATED INTERIM FINANCIAL STATEMENTS AS OF JUNE 30, 2019. exhibit_2.htm EX-99 366256
4 REGISTRANT'S OPERATING AND FINANCIAL REVIEW AS OF JUNE 30, 2019. exhibit_3.htm EX-99 170824
11 image0.jpg GRAPHIC 5551
  Complete submission text file 0001178913-19-002055.txt   2010466

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT blrx-20190630.xml EX-101.INS 187933
6 XBRL TAXONOMY EXTENSION SCHEMA blrx-20190630.xsd EX-101.SCH 31772
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE blrx-20190630_cal.xml EX-101.CAL 39434
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE blrx-20190630_def.xml EX-101.DEF 44024
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE blrx-20190630_lab.xml EX-101.LAB 181813
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blrx-20190630_pre.xml EX-101.PRE 103323
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35223 | Film No.: 191000408
SIC: 2834 Pharmaceutical Preparations